NYSE - Delayed Quote • USD
Thermo Fisher Scientific Inc. (TMO)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 5:30 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 21 | 21 | 26 | 26 |
| Avg. Estimate | 5.13 | 5.45 | 21.64 | 24.23 |
| Low Estimate | 4.99 | 5.28 | 21.42 | 22.25 |
| High Estimate | 5.36 | 5.69 | 22 | 25.27 |
| Year Ago EPS | 5.15 | 5.69 | 21.55 | 21.64 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 19 | 19 | 25 | 25 |
| Avg. Estimate | 10.52B | 10.73B | 42.92B | 46.02B |
| Low Estimate | 10.38B | 10.37B | 42.34B | 45.23B |
| High Estimate | 10.78B | 10.94B | 43.46B | 46.69B |
| Year Ago Sales | 10.98B | 10.57B | 42.86B | 42.92B |
| Sales Growth (year/est) | -4.20% | 1.40% | 0.20% | 7.20% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 5.42 | 5.61 | 5.64 | 4.71 |
| EPS Actual | 5.15 | 5.69 | 5.67 | 5.11 |
| Difference | -0.27 | 0.08 | 0.03 | 0.4 |
| Surprise % | -5.00% | 1.40% | 0.50% | 8.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 5.13 | 5.45 | 21.64 | 24.23 |
| 7 Days Ago | 5.12 | 5.58 | 21.55 | 24.07 |
| 30 Days Ago | 5.13 | 5.58 | 21.57 | 24.14 |
| 60 Days Ago | 5.14 | 5.58 | 21.56 | 24.15 |
| 90 Days Ago | 5.22 | 5.57 | 22.04 | 24.67 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 8 | 2 | 15 | 14 |
| Up Last 30 Days | 8 | 3 | 17 | 14 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 7 | 15 | 4 | 3 |
Growth Estimates
| CURRENCY IN USD | TMO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -0.40% | -- | -- | 6.50% |
| Next Qtr. | -4.20% | -- | -- | 12.00% |
| Current Year | 0.40% | -- | -- | 5.30% |
| Next Year | 12.00% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 6.63% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 12.89% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/25/2024 |
| Maintains | Deutsche Bank: Buy to Buy | 4/25/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 4/25/2024 |
| Maintains | Baird: Outperform to Outperform | 4/25/2024 |
| Maintains | HSBC: Buy to Buy | 4/17/2024 |
| Maintains | Goldman Sachs: Buy to Buy | 4/10/2024 |
Related Tickers
DHR Danaher Corporation
246.58
+0.32%
MEDP Medpace Holdings, Inc.
395.93
+1.58%
DGX Quest Diagnostics Incorporated
134.26
-0.86%
ILMN Illumina, Inc.
122.28
+1.02%
LH Laboratory Corporation of America Holdings
198.40
+0.03%
IDXX IDEXX Laboratories, Inc.
499.30
+2.06%
A Agilent Technologies, Inc.
137.74
+1.00%
WAT Waters Corporation
311.30
+0.96%
CRL Charles River Laboratories International, Inc.
229.03
+0.54%
EXAS Exact Sciences Corporation
58.85
+0.10%